Despite improvements in perinatal care, preterm birth still occurs regularly and the
associated brain injury and adverse neurological outcomes remain a persistent challenge …

Antenatal administration of magnesium sulfate is an important part of the neuroprotective
strategy for preterm infants. Strong evidence from five randomized controlled trials and five …

Magnesium sulphate (MgSO4) given to women in preterm labor reduces cerebral palsy in
their offspring but the mechanism behind this protection is unclear, limiting its effective, safe …

Maternal magnesium sulphate (MgSO4) treatment is widely recommended before preterm
birth for neuroprotection. However, this is controversial because there is limited evidence …

Magnesium (Mg) is an essential mineral in the body, impacting the synthesis of
biomacromolecules, bone matrix development, energy production, as well as heart, nerve …

Key points We evaluated the effect of magnesium sulphate (MgSO4) on seizures induced by
asphyxia in preterm fetal sheep. MgSO4 did not prevent seizures, but significantly reduced …

Magnesium sulfate is now widely recommended for neuroprotection for preterm birth;
however, this has been controversial because there is little evidence that magnesium sulfate …

Introduction The optimal dosing regimen of magnesium sulfate for treating preeclampsia and
eclampsia is unclear. Evidence from the Cochrane review of randomized controlled trials …

Key points Magnesium sulphate is the recommended treatment for pre‐eclampsia and is
now widely recommended for perinatal neuroprotection. MgSO4 has vasodilatory and …

Background Brain injury in preterm infants represents a substantial clinical problem
associated with development of motor impairment, cognitive deficits and psychiatric …